NovaBay Pharmaceuticals Inc (NYSE American:NBY)

3.31
Delayed Data
As of Apr 23
 -0.024 / -0.72%
Today’s Change
2.25
Today|||52-Week Range
5.00
-14.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash5.4M2.4M9.5M3.2M
 
 
 
 
 
Short Term Investment Cash-5.1M-3.0M7.1M-6.3M
 
 
 
 
 
Cash & Short Term Investments5.4M2.4M9.5M3.2M
 
 
 
 
 
 
ReceivablesReceivables273.0K536.0K2.1M3.7M
 
 
 
 
 
 
InventoriesInventories521.0K1.3M873.0K504.0K
 
 
 
 
 
 
Current AssetsPrepaid Expenses------1.2M
 
 
Other Current Assets729.0K261.0K2.0M347.0K
 
 
 
 
 
Current Assets7.0M4.5M14.5M9.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.0M2.1M520.0K714.0K
 
 
 
 
 
Depreciation-1.5M-1.7M-149.0K-243.0K
 
 
 
 
 
Other Assets149.0K155.0K539.0K613.0K
 
 
 
 
 
Total Assets7.5M5.1M15.4M10.1M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.9M2.5M455.0K466.0K
 
 
 
 
 
Accrued Expenses388.0K776.0K1.8M564.0K
 
 
 
 
 
Other Current Liabilities813.0K946.0K3.9M3.4M
 
 
 
 
 
Other Liabilities3.3M4.6M4.3M5.0M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.001.7M0.000.00
 
 
Other Liabilities173.0K1.6M2.0M2.0M
 
 
 
 
 
Total Liabilities5.7M10.2M8.3M7.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity1.8M-5.1M7.1M2.6M
 
 
 
 
 
Total Shareholder Equity1.8M-5.1M7.1M2.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.1M3.5M15.3M15.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.